Using a dye to guide liver tumor surgery with a camera
Part of Cancer, Digestive system clinical trials.
This trial tests a new way to help surgeons see liver tumors more clearly during keyhole (laparoscopic) surgery. A special dye (ICG) is used with a camera to guide the surgeon in removing just the right part of the liver. It may lead to safer and more precise surgery for people with liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old with liver cancer that can be removed by keyhole surgery.
- Your liver function must be fairly good (Child-Pugh grade A or B).
- You must be able to take care of yourself (ECOG score 0 or 1) and expected to live at least 3 more months.
- Your blood counts, liver and kidney test results must be within certain safe limits.
- You cannot be allergic to the dye used in this study (ICG), and you must not have had recent stomach or esophageal bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
This trial tests a special dye that targets liver cancer cells to help surgeons see tumor edges more clearly during surgery. It may help ensure all cancer is removed in one operation.
This trial tests a new way to remove liver cancer during surgery. A special dye called ICG is injected into the artery leading to the liver, which makes the tumor glow under a special camera, helping the surgeon remove just the right area. This study checks if this technique is both safe and effective for people with a common type of liver cancer (hepatocellular carcinoma).
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
This trial studies whether a special fluorescent dye that targets GPC3 can help surgeons find liver cancer more clearly during an operation. It may improve how accurately tumor tissue is identified while you have surgery for hepatocellular carcinoma.
This trial tests whether an “ICG” dye and special camera can help surgeons see cancer more clearly during surgery for advanced stomach cancer. It may help improve how safely and accurately surgeons remove the tumor and nearby lymph nodes.
Hear when a new Randomized Controlled Trial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.